showed a trendP = 0.061
Postoperative biologics showed a trend toward improved outcomes compared to immunomodulators (77.3% vs 54.5%, HR = 2.624, 95% CI: 0.955–7.214, P = 0.061).
Postoperative biologics showed a trend toward improved outcomes compared to immunomodulators (77.3% vs 54.5%, HR = 2.624, 95% CI: 0.955–7.214, P = 0.061).